These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20405137)

  • 1. Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2.
    Walter MC; Czermin B; Muller-Ziermann S; Bulst S; Stewart JD; Hudson G; Schneiderat P; Abicht A; Holinski-Feder E; Lochmüller H; Chinnery PF; Klopstock T; Horvath R
    J Neurol; 2010 Sep; 257(9):1517-23. PubMed ID: 20405137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions.
    Di Fonzo A; Bordoni A; Crimi M; Sara G; Del Bo R; Bresolin N; Comi GP
    Hum Mutat; 2003 Dec; 22(6):498-9. PubMed ID: 14635118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1.
    Ferraris S; Clark S; Garelli E; Davidzon G; Moore SA; Kardon RH; Bienstock RJ; Longley MJ; Mancuso M; Gutiérrez Ríos P; Hirano M; Copeland WC; DiMauro S
    Arch Neurol; 2008 Jan; 65(1):125-31. PubMed ID: 18195150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camptocormia as a Novel Phenotype in a Heterozygous
    Lehmann Urban D; Motlagh Scholle L; Alt K; Ludolph AC; Rosenbohm A
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31991853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population.
    González-Vioque E; Blázquez A; Fernández-Moreira D; Bornstein B; Bautista J; Arpa J; Navarro C; Campos Y; Fernández-Moreno MA; Garesse R; Arenas J; Martín MA
    Arch Neurol; 2006 Jan; 63(1):107-11. PubMed ID: 16401742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing identifies a homozygous POLG2 missense variant in an infant with fulminant hepatic failure and mitochondrial DNA depletion.
    Varma H; Faust PL; Iglesias AD; Lagana SM; Wou K; Hirano M; DiMauro S; Mansukani MM; Hoff KE; Nagy PL; Copeland WC; Naini AB
    Eur J Med Genet; 2016 Oct; 59(10):540-5. PubMed ID: 27592148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic PEO caused by a novel POLG variation and a Twinkle mutation: digenic inheritance?
    Da Pozzo P; Rubegni A; Rufa A; Cardaioli E; Taglia I; Gallus GN; Malandrini A; Federico A
    Neurol Sci; 2015 Sep; 36(9):1713-5. PubMed ID: 26050231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma.
    Filosto M; Mancuso M; Nishigaki Y; Pancrudo J; Harati Y; Gooch C; Mankodi A; Bayne L; Bonilla E; Shanske S; Hirano M; DiMauro S
    Arch Neurol; 2003 Sep; 60(9):1279-84. PubMed ID: 12975295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability.
    Ronchi D; Di Fonzo A; Lin W; Bordoni A; Liu C; Fassone E; Pagliarani S; Rizzuti M; Zheng L; Filosto M; Ferrò MT; Ranieri M; Magri F; Peverelli L; Li H; Yuan YC; Corti S; Sciacco M; Moggio M; Bresolin N; Shen B; Comi GP
    Am J Hum Genet; 2013 Feb; 92(2):293-300. PubMed ID: 23352259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zebrafish polg2 knock-out recapitulates human POLG-disorders; implications for drug treatment.
    Brañas Casas R; Zuppardo A; Risato G; Dinarello A; Celeghin R; Fontana C; Grelloni E; Gilea AI; Viscomi C; Rasola A; Dalla Valle L; Lodi T; Baruffini E; Facchinello N; Argenton F; Tiso N
    Cell Death Dis; 2024 Apr; 15(4):281. PubMed ID: 38643274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel POLG splice site mutation and optic atrophy.
    Milone M; Wang J; Liewluck T; Chen LC; Leavitt JA; Wong LJ
    Arch Neurol; 2011 Jun; 68(6):806-11. PubMed ID: 21670405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of ANT1, TWINKLE and POLG in patients with multiple deletions or depletion of mitochondrial DNA by a dHPLC-based assay.
    Naïmi M; Bannwarth S; Procaccio V; Pouget J; Desnuelle C; Pellissier JF; Rötig A; Munnich A; Calvas P; Richelme C; Jonveaux P; Castelnovo G; Simon M; Clanet M; Wallace D; Paquis-Flucklinger V
    Eur J Hum Genet; 2006 Aug; 14(8):917-22. PubMed ID: 16639411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions.
    Tyynismaa H; Ylikallio E; Patel M; Molnar MJ; Haller RG; Suomalainen A
    Am J Hum Genet; 2009 Aug; 85(2):290-5. PubMed ID: 19664747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics.
    Pitceathly RD; Smith C; Fratter C; Alston CL; He L; Craig K; Blakely EL; Evans JC; Taylor J; Shabbir Z; Deschauer M; Pohl U; Roberts ME; Jackson MC; Halfpenny CA; Turnpenny PD; Lunt PW; Hanna MG; Schaefer AM; McFarland R; Horvath R; Chinnery PF; Turnbull DM; Poulton J; Taylor RW; Gorman GS
    Brain; 2012 Nov; 135(Pt 11):3392-403. PubMed ID: 23107649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations.
    Milone M; Brunetti-Pierri N; Tang LY; Kumar N; Mezei MM; Josephs K; Powell S; Simpson E; Wong LJ
    Neuromuscul Disord; 2008 Aug; 18(8):626-32. PubMed ID: 18585914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial progressive external opthalmoplegia, parkinsonism and polyneuropathy associated with POLG1 mutation].
    Mukai M; Sugaya K; Matsubara S; Cai H; Yabe I; Sasaki H; Nakano I
    Rinsho Shinkeigaku; 2014; 54(5):417-22. PubMed ID: 24943079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete loss of expression of the ANT1 gene causing cardiomyopathy and myopathy.
    Echaniz-Laguna A; Chassagne M; Ceresuela J; Rouvet I; Padet S; Acquaviva C; Nataf S; Vinzio S; Bozon D; Mousson de Camaret B
    J Med Genet; 2012 Feb; 49(2):146-50. PubMed ID: 22187496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive external ophthalmoplegia in southwestern Finland: a clinical and genetic study.
    Martikainen MH; Hinttala R; Röyttä M; Jääskeläinen S; Wendelin-Saarenhovi M; Parkkola R; Majamaa K
    Neuroepidemiology; 2012; 38(2):114-9. PubMed ID: 22377773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype.
    Komulainen T; Hinttala R; Kärppä M; Pajunen L; Finnilä S; Tuominen H; Rantala H; Hassinen I; Majamaa K; Uusimaa J
    BMC Neurol; 2010 May; 10():29. PubMed ID: 20438629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders.
    Cohen BH; Naviaux RK
    Methods; 2010 Aug; 51(4):364-73. PubMed ID: 20558295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.